Skip to main content

OPEN ACCESS: Front-Line Solutions to Enhance Solubility & Enable Bioavailability

Thank you

This live web event has ended. Thank you for attending.


  • Dave A. Miller, Ph.D. (DisperSol Technologies)

    Dave A. Miller, Ph.D. has served as Vice President of Research and Development at DisperSol Technologies since 2011. Prior to joining DisperSol, he was a Senior Principal Scientist at Hoffmann-La Roche, Inc. in Nutley, NJ. Dr. Miller specializes in formulation and processing technologies for improving oral bioavailability of insoluble small molecules. He has applied his expertise toward advancing numerous drug candidates through various stages of development from early discovery to commercial-ready stages. Dr. Miller was an original inventor of the pharmaceutical applications of the KinetiSol technology and continues to be a primary innovative driver for application and expansion of the platform. He has published 27 research articles in peer-reviewed journals, authored 7 book chapters, and is co-editor of the First and Second Editions of the textbook, Formulating Poorly Water-Soluble Drugs. He has 7 granted patents worldwide and numerous pending applications. Dr. Miller holds a B.S. in Chemical Engineering and a Ph.D. in Pharmaceutics from the University of Texas at Austin.

October 18, 2017
Wed 12:30 PM EDT

Duration 1H 30M

This live web event has ended.